Digipath’s Chief Science Officer Calls For Cannabis Testing Science Standardization

NEVADA: Digipath, an independent cannabis testing laboratory and media firm, announced that its Chief Science Officer, Dr. Cindy Orser, has been invited to present on the science of cannabis at two upcoming events occurring in Nevada and California.

The first event will be at the Annual meeting of the California Association of Toxicologists entitled A House Full of Tox, being hosted by the Henderson Police Department’s and the Las Vegas Metropolitan Police Department’s forensic laboratories, and will take place Monday, November 6 and Tuesday, November 7 at the Golden Nugget hotel in Las Vegas, Nevada. From 1:30 pm to 2:30 pm on Tuesday, November 7, Dr. Orser will present on the current state of cannabis science in Nevada to enable California Toxicologists to get a snapshot of what’s to come in California with the role of a regulated cannabis industry.

The second speaking invitation came from the Genetic and Environmental Toxicology Association (GETA) of Northern Californiai. The event is entitled, The Science of Cannabis: Endocannabinoid Signaling and Pesticides in Cannabis Cultivation, and will take place Thursday, December 7 from 1:00 pm to 5:00 pm at the Elihu M. Harris State Office Building in Oakland, California.  Dr. Orser will present on the need for standardization in the cannabis industry as a prelude to the ensuing regulatory challenges ahead for the State of California under a newly regulated cannabis industry.

Dr. Cindy Orser, Chief Science Officer of Digipath, commented, “Digipath Labs is enthusiastic about participating in the scientific discussion regarding California’s burgeoning cannabis industry.”


Steep Hill Hawaii Announces ISO Certification For First Licensed Cannabis Testing Lab In Hawaii

HAWAII: Dana Ciccone, CEO of Steep Hill Hawaii, the first state-licensed cannabis testing lab in Hawaii, announced it received ISO/IEC 17025:2005 certification by Perry Johnson Laboratory Accreditation Inc., an international accrediting agency recognized by governments and industry participants around the world as the standard of excellence for the operation of a quality laboratory management system.

Ciccone said in making the announcement on the achievement of the Certificate of Accreditation, “We are proud not only to be the first cannabis lab to be licensed in the State of Hawaii, but also now the first lab to achieve ISO certification, as well. Industry businesses, medical professionals, state regulators, and patients can be confident that our lab and its testing standards will operate to the highest international standards. This is a turning point for the industry – we have moved very quickly to raise the industry standards in Hawaii to internationally recognized certification. I am very proud of our scientific team’s professionalism and hard work to achieve this certification.”

Steep Hill Hawaii will run full-service testing for cannabinoid profiles (potency), terpenes, pesticides, heavy metals, biological screening, and residual solvents, testing for 17 cannabinoids and 43 terpenes. The company will test for industry businesses and in-state patient cardholders, and it has been structured to provide services to be affordable, with quick turn-around times. Steep Hill Hawaii is a locally owned and operated company.


WSLCB Notice of Rule Making – Proposed Rules – #17-05: Pesticides & Lab Testing

WASHINGTON: The Washington State Liquor and Cannabis Board would like your input on the attached proposed rule changes to create and amend rules related to lab testing, quality assurance, pesticide action levels, and related topics in Chapter 314-55 WAC. This is a supplemental CR-102 filing of previously filed rules related to this topic. The proposed rules and small business economic impact statement (SBEIS) accompany this notice.

This notice can be found at lcb.wa.gov/laws/laws-and-rules under Proposed Rules. 

The Liquor and Cannabis Board encourages you to give input on this rule making.  Following the comment period the board will hold a public hearing before the rule changes may be adopted.

Public Comment

Please forward your comments to the Liquor and Cannabis Board by mail, e-mail, or fax by May 3, 2017.

By mail:      Rules Coordinator                By e-mail:             By fax:

                    Liquor and Cannabis Board   rules@lcb.wa.gov   360-664-9689

                    P.O. Box 43080

                    Olympia, WA  98504-3080


Public          May 3, 2017

Hearing:       10:00 a.m.

                    Washington State Liquor and Cannabis Board – Board Room

                    3000 Pacific Ave. S.E, Olympia, WA



ACCL Announces Pesticide Warning For Cannabis In North America

CALIFORNIA: The Association of Commercial Cannabis Laboratories (ACCL) released a statement today offering information on the continuing concern of pesticide contamination on Cannabis.

ACCL members in several states have detected high levels of various cultivating agents that are being used to combat numerous types of fungal and insect based assaults during cultivation.  As member laboratories continue to advance their technical sophistication using state-of-the art mass spectrometry-based approaches, we have broadened the ability to detect more of these cultivating agents and have come to understand that this problem is larger and more complex than anyone initially suspected.

While challenging to detail an accurate picture in the face of complex and continuously evolving laws and regulations around cannabis cultivation practices, collectively our most recent assessment of the prevalence of pesticides and fungicides shows that around 50% or more of the commercially available flowers and concentrates may contain concerning levels of these types of harmful chemical residues.

“It is the most important quality issue regarding medical and adult use Cannabis today,” says Dr. Robert Martin, ACCL Executive Director. “Pesticide residues are not known to breakdown by heat of process or by biodegradation and remain toxic in the plant or soil for lengthy periods of time.”

Fully recognizing this concern and aiming to best protect all cannabis consumers, especially those who are immunocompromised or seeking therapeutic and therefore consistent and constant uses of cannabis, ACCL members are uniting nationwide to collaborate on establishing cultivating agent testing standards and methods that will offer informed scientific leadership to the rapidly evolving cannabis industry.

Dr. Jeffrey C. Raber, ACCL President, states, “Cultivating agent contamination is a huge concern for cannabis. Collectively the broad based and accurately informed perspective of ACCL member organizations lends to a unique collective intelligence that is best capable of solving this important problem. By coming together to share our experiences and insights we believe we can arrive at an effective and viable solution to this problem that will most quickly allow for the introduction of responsible regulations and laws to best protect all cannabis consumers.”

All ACCL member organizations strongly believe in being part of a responsible, well-regulated and clean supply chain for the cannabis industry and are fully committed to actively contributing considerable amounts of time and effort to provide technical solutions to the detection and eventual eradication of this contamination concern.

Digipath’s Todd Denkin On The Passage of Recreational Cannabis in Nevada and Impact On Lab Testing Market

NEVADA: Digipath, an independent cannabis lab testing and media firm, believes that Nevada’s recent approval of the recreational use of cannabis will push the industry to more standardized lab testing practices, resulting in a highly favorable long-term impact on Nevada’s cannabis lab testing market.

The combination of shifting public opinion and success experienced over the past two years by legal medical and recreational cannabis states has given rise to the passage of new cannabis regulations and has offered voters the confidence to pass new legislative initiatives, as reflected by the outcome of the 2016 elections. In the recent November elections, Nevada residents voted to legalize recreational cannabis, a move that enables the state’s 42 million yearly visitors to purchase and consume marijuana legally. Nevada, along with California, Massachusetts, and Maine now join Colorado, Washington, Oregon, and Alaska in legalizing marijuana for adult recreational use.

Recreational cannabis in Nevada is estimated to generate more than $1.1 billion in tax revenue and economic activity over the course of the law’s initial eight years, according to a study by Las Vegas-based RCG Economics. For the first 18 months after the legalization of recreational marijuana, current medical marijuana state registration certificate holders (dispensary owners) will have priority on building new facilities for recreational marijuana. That includes new dispensaries, cultivation and testing facilities, and manufacturing facilities for paraphernalia.

Todd Denkin, President and COO of Digipath, commented, “As the Nevada recreational market becomes operational, the increase in the number of potential consumers and cultivation facilities is expected to push the industry’s focus towards more standardized cannabis lab testing and recognition of the value of the data collected through the testing process in ensuring consumer safety. Commercial cannabis cultivators and producers understand that laboratory testing is one of the vital platform technologies in the cannabis marketplace, and it must become standardized, consistent, and robust in order to maintain the long term health of the cannabis industry.”